• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR ARMADA 35 PTA CATHETER; PERIPHERAL DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR ARMADA 35 PTA CATHETER; PERIPHERAL DILATATION CATHETER Back to Search Results
Catalog Number B2050-040
Medical Device Problem Codes Leak/Splash (1354); Improper or Incorrect Procedure or Method (2017)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 04/11/2024
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that the procedure was to treat a lesion in the right superficial femoral artery (rsfa).The 5x40mm armada 35 balloon dilatation catheter (bdc) was advanced to the target lesion and the the balloon was inflated to 12 atmospheres (atm); however, a leak was noted outside the anatomy at the black part of the hub.The leak was noted by a drip of the contrast/saline mixture.The balloon was able to be deflated and removed from the patient without issue.There was no adverse patient effect and no clinically significant delay reported in the procedure.No additional information was provided.
 
Additional Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Additional Manufacturer Narrative
Visual and functional analysis was performed on the returned device.The reported leak was not confirmed.Production record and corrective and preventive actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a review of the complaint history identified no other similar complaints from this lot.It was reported that the contrast mix used in the procedure was 70% saline/ 30% contrast.It should be noted that the percutaneous transluminal angioplasty catheter (pta), armada 35 / armada 35 ll, global, instructions for use (ifu) specified that the contrast is 60% contrast medium diluted 1:1 with normal saline.In this case, since the contrast ratio used was less than the required percentage it is unknown if the ifu violation caused or contributed to the reported complaint.Based on the information reported through the complaint report, a conclusive cause for the reported leak could not be determined.Possible factors that may contribute to a leak include, but are not limited to, manufacturing, damage to the sidearm/inflation lumen, damage to the balloon or loose connections.In this case, a conclusive cause for the reported leak could not be determined since the complaint was not confirmed during analysis.There is no indication of a product quality issue with respect to manufacture, design or labeling.H6 medical device problem code 2017: contrast incorrect.
 
Event or Problem Description
Subsequent to the previously filed report, the initial information was further reviewed and it was noted that a 70/30 contrast ratio was used.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARMADA 35 PTA CATHETER
Common Device Name
PERIPHERAL DILATATION CATHETER
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR COSTA RICA, REG # 3009564766
52 calle 3 b31 coyol free zone
el coyol alajuela
CS  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key19233115
Report Number2024168-2024-05398
Device Sequence Number6016104
Product Code LIT
UDI-Device Identifier08717648155178
UDI-Public(01)08717648155178(17)250228(10)10910G1
Combination Product (Y/N)N
Initial Reporter StateKS
Initial Reporter CountryUS
PMA/510(K) Number
K111899
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 06/21/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Expiration Date02/28/2025
Device Catalogue NumberB2050-040
Device Lot Number10910G1
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer04/25/2024
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Follow-Up
Initial Date Received by Manufacturer 04/11/2024
Supplement Date Received by Manufacturer06/19/2024
Initial Report FDA Received Date05/02/2024
Supplement Report FDA Received Date06/21/2024
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured09/10/2021
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-